← Leaderboards
Jennifer M Martin
University Of Colorado At Boulder
$1,852,276
Attributed
$2,165,366
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $313.4K · FY2005–10$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$2,165,366 · 3
By mechanism
R01$1,292,746 · 1
R21$626,181 · 1
K02$246,439 · 1
Top collaborators
- Hang Hubert Yin7 shared
Most similar at University Of Colorado At Boulder
Same institution · by research overlap
- Rebecca E Schweppe$4,544,172
- Kristi S. Anseth$19,055,455
- Tad H Koch$1,470,539
- Corrella Detweiler$9,057,771
Others in their field
Top investigators on “Cell Transformation”
- Hugh Rosen · Scripps Research Institute$67,361,551
- Mary L. Disis · University Of Washington$62,859,950
- Georgia D Tomaras · Fred Hutchinson Cancer Center$58,263,037
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$58,263,037
- Dan H. Barouch · Fred Hutchinson Cancer Center$58,263,037
- Lawrence Corey · Fred Hutchinson Cancer Center$58,263,037
Research focus
Cell TransformationMembrane ProteinsAnalogOncogene ProteinsResearch StudyTumor Necrosis Factor ReceptorCellsInfected B CellMediatingMembraneDesignProteinsSignal TransductionTransmembrane DomainInsightIn VitroBaseB-LymphocytesLightMalignant NeoplasmsPlayMembrane MicrodomainsArtificial MembranesArts
Grant awards (17)
Probing EBV-LMP-1's Transmembrane Activation Domain with Synthetic Peptide Antago$197,445
R21 · FY2010 · CA
Probing EBV-LMP-1's Transmembrane Activation Domain with Synthetic Peptide Antago$57,679
R21 · FY2010 · CA
Probing EBV-LMP-1's Transmembrane Activation Domain with Synthetic Peptide Antago$57,679
R21 · FY2010 · CA
Probing EBV-LMP-1's Transmembrane Activation Domain with Synthetic Peptide Antago$164,189
R21 · FY2009 · CA
Probing EBV-LMP-1's Transmembrane Activation Domain with Synthetic Peptide Antago$54,050
R21 · FY2009 · CA
Probing EBV-LMP-1's Transmembrane Activation Domain with Synthetic Peptide Antago$49,535
R21 · FY2009 · CA
Probing EBV-LMP-1's Transmembrane Activation Domain with Synthetic Peptide Antago$45,604
R21 · FY2009 · CA
Activation of the LMP-1 Protein of Epstein-Barr Virus$231,698
R01 · FY2008 · CA · contact PI
Activation of the LMP-1 Protein of Epstein-Barr Virus$46,501
R01 · FY2008 · CA · contact PI
Activation of the LMP-1 Protein of Epstein-Barr Virus$231,698
R01 · FY2007 · CA · contact PI
Activation of the LMP-1 Protein of Epstein-Barr Virus$56,741
R01 · FY2007 · CA · contact PI
Activation of the LMP-1 Protein of Epstein-Barr Virus$238,618
R01 · FY2006 · CA · contact PI
Activation of the LMP-1 Protein of Epstein-Barr Virus$244,155
R01 · FY2005 · CA
Activation of the LMP-1 Protein of Epstein-Barr Virus$243,335
R01 · FY2004 · CA
HUMAN B CELL TRANSFORMATION BY EPSTEIN BARR VIRUS$90,320
K02 · FY2002 · AI
HUMAN B CELL TRANSFORMATION BY EPSTEIN BARR VIRUS$88,575
K02 · FY2001 · AI
HUMAN B CELL TRANSFORMATION BY EPSTEIN BARR VIRUS$67,544
K02 · FY2000 · AI